Status:
COMPLETED
Health Status, Quality of Life and Function in Survivors After Radical Treatment for Prostate Cancer. Part IIB
Lead Sponsor:
Sykehuset Innlandet HF
Collaborating Sponsors:
Norwegian University of Science and Technology
Conditions:
Prostate Cancer
Survivorship
Eligibility:
MALE
70+ years
Brief Summary
The present study is the last part of a larger project investigating the health, quality of life and function of men having received radical treatment for prostate cancer in 2014-2018. In this study, ...
Detailed Description
Background: Prostate cancer is the most common cancer among Norwegian men with about 5000 new cases each year. Median age at diagnosis is 70 years. Radical treatment for local or locally advanced pro...
Eligibility Criteria
Inclusion
- Inclusion Criteria, Study group:
- having received radical radiotherapy or robot-assisted radical prostatectomy for prostate cancer at Innlandet Hospital Trust 01.01.2014 and 31.12.2018
- alive and living in Innlandet County
- fluent in Norwegian (orally and in writing)
- provide written informed consent
- age 70 years or more by the time of treatment
- having participated in the foregoing parts of the overarching project, part I and IIA (NCT04863352), both cross-sectional studies using questionnaires/patient reported outcome measures.
- Exclusion Criteria:
- \- survivors with clinically significant relapse (verified metastases/local progression and/or start of lifelong antiandrogen therapy)
Exclusion
Key Trial Info
Start Date :
December 21 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 20 2022
Estimated Enrollment :
109 Patients enrolled
Trial Details
Trial ID
NCT05200039
Start Date
December 21 2021
End Date
August 20 2022
Last Update
January 18 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Innlandet Hospital Trust
Brumunddal, Norway, 2381